BIOMAT Database Logo BIOMAT Database Logo

Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. 2010

Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Neurological Clinic, University of Ulm, Germany.

OBJECTIVE Myotonic dystrophy type 1 and 2 (DM1/DM2) are multisystemic diseases with common cognitive deficits beside the cardinal muscular symptoms. We performed a comprehensive analysis of cerebral abnormalities to compare the neuropsychological defects with findings in different imaging methods in the same cohort of patients. METHODS Neuropsychological investigations, structural cerebral MRI including brain parenchymal fraction (BPF) and voxel-based morphometry (VBM), and (18)F-deoxy-glucose PET (FDG-PET) were performed in patients (20 DM1 and 9 DM2) and matched healthy controls, and analyzed using statistical parametric mapping (SPM2). RESULTS DM1 and DM2 patients showed typical neuropsychological deficits with a pronounced impairment of nonverbal episodic memory. Both patient groups showed a reduction of the global gray matter (measured by BPF), which could be localized to the frontal and parietal lobes by VBM. Interestingly, VBM revealed a bilateral hippocampal volume reduction that was correlated specifically to both a clinical score and episodic memory deficits. VBM also revealed a pronounced change of thalamic gray matter. White matter lesions were found in >50% of patients and their extent was correlated to psychomotor speed. FDG-PET revealed a frontotemporal hypometabolism, independent of the decrease in cortical gray matter. All abnormalities were similar in both patient groups but more pronounced for DM1. CONCLUSIONS Our results suggest that 1) some of the characteristic cognitive deficits of these patients are linked to specific structural cerebral changes, 2) decreases in gray matter and metabolism are independent processes, and 3) the widespread brain abnormalities are more pronounced in DM1.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009223 Myotonic Dystrophy Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2. Dystrophia Myotonica,Myotonic Dystrophy, Congenital,Myotonic Myopathy, Proximal,Steinert Disease,Congenital Myotonic Dystrophy,Dystrophia Myotonica 1,Dystrophia Myotonica 2,Myotonia Atrophica,Myotonia Dystrophica,Myotonic Dystrophy 1,Myotonic Dystrophy 2,PROMM (Proximal Myotonic Myopathy),Proximal Myotonic Myopathy,Ricker Syndrome,Steinert Myotonic Dystrophy,Steinert's Disease,Atrophica, Myotonia,Atrophicas, Myotonia,Congenital Myotonic Dystrophies,Disease, Steinert,Disease, Steinert's,Dystrophia Myotonica 2s,Dystrophia Myotonicas,Dystrophica, Myotonia,Dystrophicas, Myotonia,Dystrophies, Congenital Myotonic,Dystrophies, Myotonic,Dystrophy, Congenital Myotonic,Dystrophy, Myotonic,Dystrophy, Steinert Myotonic,Myopathies, Proximal Myotonic,Myopathy, Proximal Myotonic,Myotonia Atrophicas,Myotonia Dystrophicas,Myotonic Dystrophies,Myotonic Dystrophies, Congenital,Myotonic Dystrophy, Steinert,Myotonic Myopathies, Proximal,Myotonica, Dystrophia,Myotonicas, Dystrophia,PROMMs (Proximal Myotonic Myopathy),Proximal Myotonic Myopathies,Steinerts Disease,Syndrome, Ricker
D009413 Nerve Fibers, Myelinated A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the myelinated nerve fibers are completely encased in a MYELIN SHEATH. They are fibers of relatively large and varied diameters. Their NEURAL CONDUCTION rates are faster than those of the unmyelinated nerve fibers (NERVE FIBERS, UNMYELINATED). Myelinated nerve fibers are present in somatic and autonomic nerves. A Fibers,B Fibers,Fiber, Myelinated Nerve,Fibers, Myelinated Nerve,Myelinated Nerve Fiber,Myelinated Nerve Fibers,Nerve Fiber, Myelinated
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001931 Brain Mapping Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures. Brain Electrical Activity Mapping,Functional Cerebral Localization,Topographic Brain Mapping,Brain Mapping, Topographic,Functional Cerebral Localizations,Mapping, Brain,Mapping, Topographic Brain
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition

Related Publications

Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.
October 2018, Current neurology and neuroscience reports,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
The neglected brain in myotonic dystrophy types 1 and 2.
April 2010, Neurology,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Myotonic dystrophy types 1 and 2.
January 2011, Handbook of clinical neurology,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Analysis of repetitive regions in myotonic dystrophy type 1 and 2.
April 2009, Current protocols in human genetics,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Social cognition in type 1 myotonic dystrophy - A mini review.
September 2021, Cortex; a journal devoted to the study of the nervous system and behavior,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Cognitive function and its relationship with brain structure in myotonic dystrophy type 1.
January 2021, Journal of neuroscience research,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
September 2002, Current neurology and neuroscience reports,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Brain disease and molecular analysis in myotonic dystrophy.
December 1994, Neuroreport,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Dysregulation of calcium metabolism in type 1 myotonic dystrophy.
November 2019, Internal medicine journal,
Y G Weber, and R Roebling, and J Kassubek, and S Hoffmann, and A Rosenbohm, and M Wolf, and P Steinbach, and K Jurkat-Rott, and H Walter, and S N Reske, and F Lehmann-Horn, and F M Mottaghy, and H Lerche
Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?
January 2018, PloS one,
Copied contents to your clipboard!